The COVID-19 pandemic had a profound effect on the world, resulting in a dramatic loss of human lives. While the situation is ...

Chronic cystitis is a condition in which cystitis recurs repeatedly more than two or three times a year or the disease ...

We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

"Patients presenting with chronic diarrhea, blood in the stool, unexplained nausea and vomiting, or unexplained weight loss ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...

It is estimated that more than 5 million people worldwide suffer from ulcerative colitis, a chronic inflammation of the colon ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

Patients suffering from eczema may find it easier to monitor their skin condition through the latest artificial intelligence ...

Sandoz announced the European launch of its Pyzchiva (ustekinumab) autoinjector. This is the first ustekinumab biosimilar in ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...